ArticleResearch square2023

Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge.

Luis de la Maza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.